AU Stock MarketDetailed Quotes

CHM Chimeric Therapeutics Ltd

Watchlist
  • 0.019
  • +0.001+5.56%
20min DelayTrading Jul 15 10:02 AET
16.39MMarket Cap-322P/E (Static)

Chimeric Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities
3.5M
Other cash income from operating activities
--3.5M
----
----
Cash paid
-51.05%-19.83M
-48.60%-13.13M
-8.84M
Payments to suppliers for goods and services
-51.05%-19.83M
-48.60%-13.13M
---8.84M
Direct interest received
--27.57K
----
----
Operating cash flow
-24.19%-16.31M
-48.60%-13.13M
---8.84M
Investing cash flow
Cash flow from continuing investing activities
80.14%-112.19K
89.35%-564.88K
-5.3M
Net PPE purchase and sale
----
24.42%-12.29K
---16.26K
Net intangibles purchas and sale
78.65%-112.19K
90.07%-525.57K
---5.29M
Net investment purchase and sale
----
---40K
----
Interest received (cash flow from investment activities)
----
390.44%12.98K
--2.65K
Cash from discontinued investing activities
Investing cash flow
80.14%-112.19K
89.35%-564.88K
---5.3M
Financing cash flow
Cash flow from continuing financing activities
-97.33%253.38K
-73.99%9.5M
36.54M
Net issuance payments of debt
45.55%-2.23M
-11,916.85%-4.09M
---34.01K
Net common stock issuance
-81.69%2.49M
-62.85%13.59M
--36.58M
Interest paid (cash flow from financing activities)
---10.3K
----
---9.58K
Cash from discontinued financing activities
Financing cash flow
-97.33%253.38K
-73.99%9.5M
--36.54M
Net cash flow
Beginning cash position
-17.98%18.38M
22,410,099.00%22.41M
--100
Current changes in cash
-285.70%-16.16M
-118.71%-4.19M
--22.4M
Effect of exchange rate changes
-10.24%145.69K
1,808.84%162.31K
--8.5K
End cash Position
-87.15%2.36M
-17.98%18.38M
--22.41M
Free cash from
-20.12%-16.42M
3.36%-13.67M
---14.14M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021
Operating cash flow (direct method)
Cash income from operating activities 3.5M
Other cash income from operating activities --3.5M--------
Cash paid -51.05%-19.83M-48.60%-13.13M-8.84M
Payments to suppliers for goods and services -51.05%-19.83M-48.60%-13.13M---8.84M
Direct interest received --27.57K--------
Operating cash flow -24.19%-16.31M-48.60%-13.13M---8.84M
Investing cash flow
Cash flow from continuing investing activities 80.14%-112.19K89.35%-564.88K-5.3M
Net PPE purchase and sale ----24.42%-12.29K---16.26K
Net intangibles purchas and sale 78.65%-112.19K90.07%-525.57K---5.29M
Net investment purchase and sale -------40K----
Interest received (cash flow from investment activities) ----390.44%12.98K--2.65K
Cash from discontinued investing activities
Investing cash flow 80.14%-112.19K89.35%-564.88K---5.3M
Financing cash flow
Cash flow from continuing financing activities -97.33%253.38K-73.99%9.5M36.54M
Net issuance payments of debt 45.55%-2.23M-11,916.85%-4.09M---34.01K
Net common stock issuance -81.69%2.49M-62.85%13.59M--36.58M
Interest paid (cash flow from financing activities) ---10.3K-------9.58K
Cash from discontinued financing activities
Financing cash flow -97.33%253.38K-73.99%9.5M--36.54M
Net cash flow
Beginning cash position -17.98%18.38M22,410,099.00%22.41M--100
Current changes in cash -285.70%-16.16M-118.71%-4.19M--22.4M
Effect of exchange rate changes -10.24%145.69K1,808.84%162.31K--8.5K
End cash Position -87.15%2.36M-17.98%18.38M--22.41M
Free cash from -20.12%-16.42M3.36%-13.67M---14.14M
Accounting Standards US-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg